Airtel Africa (LSE: AAF) has been among the standout performers in the FTSE 100 since joining the blue-chip index in January 2022, surging 124% over that period. Investors who backed the African
A US federal appeals court has ruled against the Washington Department of Fish and Wildlife after it failed to properly accommodate employees’ religious objections to COVID-19 vaccination. The case, *Cherry et al.
MoreClio has appointed Pablo Arredondo as senior vice president, judiciary, marking the company’s first dedicated move to extend its technology into the courts. Arredondo cofounded Casetext in 2013 after working as a
MoreUK stocks made modest gains on Tuesday as Bitcoin extended its rally to a more than three-month high, supporting broader investor risk appetite. The FTSE 100 gained 0.15% as of 03:25 ET,
MoreA prominent executive search firm operating at the heart of FTSE recruitment has been rescued from administration by a competing rival in the sector. The firm, which specialised in placing senior leaders
MoreBausch + Lomb has developed a first-in-class combination eye drop targeting two of the primary underlying causes of dry eye disease simultaneously. The novel treatment combines 5% lifitegrast, the active ingredient in
MoreCourts across the United States are increasingly grappling with federal preemption arguments as a central battleground in litigation involving regulated industries. Once considered a largely defensive legal tool, preemption was historically raised
MoreJustice Ketanji Brown Jackson has delivered a fierce dissent targeting the shadow docket, describing the situation facing election challengers as a “Kafkaesque nightmare.” The dissent focuses on the procedural framework the Supreme
MoreDick’s Sporting Goods saw its stock fall sharply by 12.3% after the retailer failed to meet second-quarter sales expectations for the 2026 calendar year. The significant share price decline reflects investor disappointment
MoreVistry Group, the housebuilder listed on the FTSE 250, saw its shares push higher as investors responded positively to developments surrounding the company. Housebuilders have faced a difficult operating environment in recent
MoreMcKesson Corporation is acquiring Precision Medicine Group for $2.25 billion, significantly expanding its drug development and commercialisation capabilities. The healthcare wholesaler, which ranks eighth on the Fortune 500 list, will fold privately
More
